Mangalam Drugs & Organics Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Govardhan Dhoot
Chief executive officer
₹2.0m
Total compensation
| CEO salary percentage | 100.0% |
| CEO tenure | 28.1yrs |
| CEO ownership | 6.8% |
| Management average tenure | no data |
| Board average tenure | 6.3yrs |
Recent management updates
Recent updates
Little Excitement Around Mangalam Drugs & Organics Limited's (NSE:MANGALAM) Revenues As Shares Take 25% Pounding
Mar 28
Mangalam Drugs & Organics Limited's (NSE:MANGALAM) Shares Lagging The Industry But So Is The Business
Feb 07Estimating The Fair Value Of Mangalam Drugs & Organics Limited (NSE:MANGALAM)
Oct 20Is Mangalam Drugs & Organics (NSE:MANGALAM) A Risky Investment?
Mar 29These 4 Measures Indicate That Mangalam Drugs & Organics (NSE:MANGALAM) Is Using Debt Extensively
May 31A Look At The Fair Value Of Mangalam Drugs & Organics Limited (NSE:MANGALAM)
Apr 06We Think Mangalam Drugs & Organics (NSE:MANGALAM) Is Taking Some Risk With Its Debt
Jan 03Here's Why Mangalam Drugs & Organics (NSE:MANGALAM) Can Manage Its Debt Responsibly
May 23Is Mangalam Drugs & Organics (NSE:MANGALAM) A Risky Investment?
Jan 04Do Its Financials Have Any Role To Play In Driving Mangalam Drugs & Organics Limited's (NSE:MANGALAM) Stock Up Recently?
Nov 12
A Look At The Intrinsic Value Of Mangalam Drugs & Organics Limited (NSE:MANGALAM)
Sep 20Does Mangalam Drugs & Organics's (NSE:MANGALAM) Statutory Profit Adequately Reflect Its Underlying Profit?
Aug 05We Think Mangalam Drugs & Organics (NSE:MANGALAM) Can Stay On Top Of Its Debt
Jul 01CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -₹170m |
| Sep 30 2023 | n/a | n/a | -₹171m |
| Jun 30 2023 | n/a | n/a | -₹113m |
| Mar 31 2023 | ₹2m | ₹2m | ₹13m |
| Dec 31 2022 | n/a | n/a | ₹123m |
| Sep 30 2022 | n/a | n/a | ₹159m |
| Jun 30 2022 | n/a | n/a | ₹182m |
| Mar 31 2022 | ₹2m | ₹2m | ₹197m |
| Dec 31 2021 | n/a | n/a | ₹151m |
| Sep 30 2021 | n/a | n/a | ₹175m |
| Jun 30 2021 | n/a | n/a | ₹241m |
| Mar 31 2021 | ₹2m | n/a | ₹280m |
| Dec 31 2020 | n/a | n/a | ₹309m |
| Sep 30 2020 | n/a | n/a | ₹261m |
| Jun 30 2020 | n/a | n/a | ₹158m |
| Mar 31 2020 | ₹5m | ₹2m | ₹83m |
| Dec 31 2019 | n/a | n/a | -₹28m |
| Sep 30 2019 | n/a | n/a | -₹89m |
| Jun 30 2019 | n/a | n/a | -₹80m |
| Mar 31 2019 | ₹2m | ₹2m | -₹80m |
| Dec 31 2018 | n/a | n/a | ₹10m |
| Sep 30 2018 | n/a | n/a | ₹114m |
| Jun 30 2018 | n/a | n/a | ₹164m |
| Mar 31 2018 | ₹2m | ₹2m | ₹199m |
Compensation vs Market: Govardhan's total compensation ($USD23.99K) is below average for companies of similar size in the Indian market ($USD39.52K).
Compensation vs Earnings: Govardhan's compensation has been consistent with company performance over the past year.
CEO
Govardhan Dhoot (70 yo)
28.1yrs
Tenure
₹2,000,000
Compensation
Mr. Govardhan Murlidhar Dhoot serves as the Chairman of the Board and Managing Director at Mangalam Drugs & Organics Limited and has been its Executive Director since April 16, 1996.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & MD | 28.1yrs | ₹2.00m | 6.81% ₹ 108.9m | |
| Whole-Time Director | 9yrs | ₹600.00k | 3.57% ₹ 57.1m | |
| Independent Director | 6.5yrs | ₹36.00k | no data | |
| Non-Executive Independent Director | 6yrs | ₹42.00k | no data | |
| Independent Non-Executive Director | 3.2yrs | ₹24.00k | no data | |
| Non-Executive Non- Independent Director | 2.2yrs | ₹16.00k | no data |
6.3yrs
Average Tenure
68yo
Average Age
Experienced Board: MANGALAM's board of directors are considered experienced (6.3 years average tenure).